top of page


Completion of ReLink Randomized Controlled Trial: A Milestone in Healthcare Innovation
We're thrilled to announce the conclusion of the ReLink randomized controlled trial, with the enrollment of the final patient marking a...
Dec 8, 2023


Expanding Our Reach: ReLink Patent Approved in Brazil!
We're delighted to share that ReLink has received patent approval in Brazil, marking a significant milestone in our journey. This...
Dec 6, 2023


Empowering Healthcare Innovation: Reflecting on Our Journey at HTC
We extend our gratitude to HTC for hosting an inspiring event that fostered meaningful connections among visionaries! At the event, Aneek...
Nov 28, 2023


An exhibitor and a returning keynote speaker at ICITAIEE
A sincere thank you to ICITAIEE and especially to Dr. Hanadi AL-Mubaraki for the gracious invitation. Engaging in meaningful discussions...
Nov 23, 2023


LSX Investival Showcase, London!
Reflecting on a remarkable time at Investival Showcase. Connecting with peers, investors, and passionate individuals who share our vision...
Nov 20, 2023


Latest patent: This time it is India
Goddess Lakshami came early this year! ✨🪔 This #Diwali, our spirits are soaring even higher as we proudly announce that our...
Nov 9, 2023


Clinical studies at Parc Sanitari Sant Joan de Deu (PSSJD), Spain
Clinical studies serve as the bedrock for establishing a medical device's safety and efficacy. Our site initiation visit at Parc Sanitari...
Nov 1, 2023


Med-Tech World 2023
We extend our heartfelt thanks to everyone who played a vital role in making Med-Tech World 2023 a resounding success! The dedication and...
Oct 25, 2023


Gratitude for Uppsala Life: A Step Towards a Sustainable Future
Gratitude for Uppsala Life: A Step Towards a Sustainable Future
Oct 20, 2023


Insights and connections from the Association for Vascular Access's annual scientific meeting
Interlinked COO, Rebecca Bejhed, has just returned from the Association for Vascular Access's Annual Scientific Meeting in Portland.
Oct 18, 2023


We're Health Tech Challengers Finalists!
Exciting news! We're thrilled to share that we've been chosen as finalists in the Health Tech Challengers. This accolade underscores our...
Oct 11, 2023


Official logo of Tada Group & upgraded website
Explore Our Evolution: Welcome to Our Upgraded Website! 🚀 Embark on our journey of growth with the unveiling of our revamped website. 🌟...
Oct 6, 2023


The Startup Club - Health Tech Investment Conference
As The Startup Club - Health Tech Investment Conference unfolds, we are eagerly preparing for a dynamic engagement filled with insightful...
Sep 27, 2023


ReLink/LinkUS has entered U.S. clinical trials.
Exciting News! ReLink has entered U.S. clinical trials, rebranded as LinkUS. This milestone is a testament to our commitment to...
Sep 15, 2023


Patent update: This time it is Malaysia
As we return from summer, our journey of global innovation continues! We're delighted to share that our ReLink technology has secured a...
Aug 18, 2023


ReLink receives warm welcome: a grateful thank you to all!
We would like to extend our heartfelt gratitude for the warm welcome extended to ReLink, as well as to Rebecca Stjernberg Bejhed and...
May 24, 2023


Uppsala University Innovation and Entrepreneurship prize ceremony!
Yesterday, our co-founder and COO, Rebecca Stjernberg Bejhed, had the honor of attending the prestigious Innovation and Entrepreneurship...
Apr 26, 2023


Reflecting on an energizing week of events in London!
The past week has been truly invigorating, leaving us with a renewed sense of energy and purpose. Our CEO, Katarina Hedbeck, expressed...
Apr 25, 2023


Patent update: This time it is South Korea
We are thrilled to announce that Tada Group has obtained patent approval for our groundbreaking ReLink safety connector in South Korea....
Dec 20, 2022


Grand win at WISH 2022 in Doha, Qatar
Honoured and humbled as ReLink & Tada emerged as the winner at the World Innovation Summit for Health (WISH) 2022 in Doha, Qatar last...
Oct 14, 2022
bottom of page